Skip to Content

Molecular Grouping of Gliomas: Clinical Implications and Utility

The webinar will briefly cover the current knowledge concerning the molecular genetic classification of adult gliomas. This part of the presentation will be based primarily on the translational research of the presenter, but it will also include complementary data from The Cancer Genome Atlas, the World Health Organization, and other groups. The presentation will continue with a description of the current genetic tests the Mayo Clinic Division of Laboratory Genetics and Genomics offers (or will soon offer) for the molecular classification of adult gliomas. It will include Mayo’s current algorithmic approach to the diagnostic workup of these devastating tumors. If sufficient time remains, the presentation will conclude with a discussion of a few example cases.

View the Archived Webinar


Robert Jenkins, M.D., Ph.D.
Consultant, Division of Laboratory Genetics and Genomics
Ting Tsung and Wei Fong Chao Professor of Individualized Medicine Research
Mayo Clinic, Rochester, Minnesota

Learning Objectives

  • Discuss the molecular genetic classification of adult gliomas.
  • Appreciate the diagnostic and predictive relevance of the classification system(s).
  • Explore an algorithm for the clinical molecular genetic workup of an adult glioma.

Intended Audience

This webinar is designed for oncologists, neurologists, pathologists, genetic counselors, and laboratory technologists.

Mayo Medical Laboratories is not an applicable manufacturer or applicable group purchasing organization (GPO). (GPOs, per the Centers for Medicare & Medicaid Services, and this program do not trigger any reporting requirements pursuant to Open Payments [Sunshine Act] legislation.)

MCL Education

MCL Education

This post was developed by our Education and Technical Publications Team.